Fundz

Ember LifeSciences Raises $16.5M in Series A Funding led by Sea Court Capital to advance its cold chain technology pipeline, including the Ember Cube 2.

PRIVATEDec 16, 2025

Amount Raised

$16.5 Million

Round Type

Series A

Westlake VillageBiotechnologyHealth Care

Investors

Cardinal HealthCarrier VenturesMike PompeoSea Court Capital

Description

Ember LifeSciences, a Los Angeles-based provider of cold chain technology, has raised $16.5M in Series A funding. The round was led by Sea Court Capital, with participation from Cardinal Health and Carrier Ventures. The funds will be used to launch the Ember Cube 2 and enhance their temperature control technology. The company aims to transform global medicine distribution.

Quick answer

Ember LifeSciences raised $16.5 Million in a Series A round, dated December 16, 2025. Investors: Cardinal Health, Carrier Ventures, Mike Pompeo and Sea Court Capital. Ember LifeSciences is based in Westlake Village, California, United States.

How much did Ember LifeSciences raise?
Ember LifeSciences raised $16.5 Million in a Series A round on December 16, 2025.
Who invested in Ember LifeSciences?
Cardinal Health, Carrier Ventures, Mike Pompeo and Sea Court Capital are named as investors in this round.
What does Ember LifeSciences do?
Ember LifeSciences is redefining global medicine distribution through leveraging Ember’s proprietary temperature control technology to improve the way we transport life-saving medicines and vaccines around the world.
Where is Ember LifeSciences based and how big is it?
Ember LifeSciences is based in Westlake Village, California, United States. Fundz records about 24 employees.
Who are the decision-makers at Ember LifeSciences?
Fundz holds 3 contacts at Ember LifeSciences, including the General Manager. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as Ember LifeSciences that raised within 45 days of this round, from Fundz verified event records.

  • ORamaVR raised $4.5M (Seed) on January 30, 2026.
  • CytoDyn raised $19M on January 30, 2026.
  • Richtech Robotics raised $39M (Post-IPO Equity) on January 29, 2026.
  • Biopeak raised $2.7M (Seed) on January 29, 2026.
  • Tenpoint Therapeutics raised $235M (Series B) on January 29, 2026.
  • PranaX raised $17M (Series A) on January 29, 2026.

Who to call at Ember LifeSciences, and when

A new round usually means Ember LifeSciences is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Ember LifeSciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Ember LifeSciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Ember LifeSciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Ember LifeSciences

Location

Westlake Village, California, United States

About

Ember LifeSciences is redefining global medicine distribution through leveraging Ember’s proprietary temperature control technology to improve the way we transport life-saving medicines and vaccines around the world. Using innovative, human-centered design and an unprecedented connectivity for shippers, we aim to save lives, improve patient outcomes and reduce waste.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Ember LifeSciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

3 contacts
Verified contactsBrian B., General ManagerSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Ember LifeSciences's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

Ember LifeSciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.